Torsten Hoffman

Title: The Innovations of Torsten Hoffman

Introduction

Torsten Hoffman is a notable inventor based in Halle/Saale, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of inhibitors for glutaminyl cyclase. With a total of three patents to his name, Hoffman's work is focused on addressing various inflammatory diseases.

Latest Patents

Hoffman's latest patents include innovative compounds that serve as inhibitors of glutaminyl cyclase. These compounds are defined by a general formula (I), where R, R, R, R, X, and Y are specified. The inhibitors are particularly useful in treating conditions that can be managed by modulating glutaminyl cyclase activity. Another significant patent outlines methods for treating inflammation using these inhibitors. The methods provided are aimed at the treatment and prevention of inflammatory diseases or disorders, including mild cognitive impairment (MCI), rheumatoid arthritis, atherosclerosis, restenosis, and pancreatitis.

Career Highlights

Torsten Hoffman is currently associated with Probiodrug AG, a company that focuses on developing innovative therapies for neurodegenerative diseases. His work at Probiodrug AG has been instrumental in advancing research in the field of glutaminyl cyclase inhibitors.

Collaborations

Hoffman has collaborated with notable colleagues such as Hans-Ulrich Demuth and Stephan Schilling. Their combined expertise has contributed to the successful development of new therapeutic approaches.

Conclusion

Torsten Hoffman is a distinguished inventor whose work in glutaminyl cyclase inhibitors has the potential to transform the treatment of various inflammatory diseases. His contributions to the field are significant and continue to pave the way for innovative therapeutic solutions.